Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120

By Pinter A.   Honnen W.J.   Kayman S.C.   Trochev O.   Wu Z.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1803-1811

Elsevier

Access to resources Recommend Favorite

Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems

By Sjolander S.   Hansen J.-E.S.   Lovgren-Bengtsson K.   &   9kerblom L.   Morein B.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 344-352

Elsevier

Access to resources Recommend Favorite

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

By Montero M.   Menendez A.   del Carmen Dominguez M.   Navea L.   Vilarubia O.L.   Quintana D.   Izquierdo M.   Jimenez V.   Reyes O.   Lobaina L.   Noa E.   Duarte C.A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1200-1208

Elsevier

Access to resources Recommend Favorite

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

By Barnett S.W.   Rajasekar S.   Legg H.   Doe B.   Fuller D.H.   Haynes J.R.   Walker C.M.   Steimer K.S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 869-873

Elsevier

Access to resources Recommend Favorite

Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus

By McLain L.   Durrani Z.   Wisniewski L.A.   Porta C.   Lomonossoff G.P.   Dimmock N.J.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 799-810

Elsevier

Access to resources Recommend Favorite